SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — May 14, 2018

DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: May 14, 2018 · CIK: 0001533998 · Accession: 0001144204-18-027896

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-224458

Date
May 14, 2018
Author
Zvi Ben David
Form
CORRESP
Company
DarioHealth Corp. (DRIO) (CIK 0001533998)

Letter

DarioHealth Corp.

8 HaTokhen Street

Caesarea Industrial Park

3088900, Israel

May 14, 2018

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

RE: DarioHealth Corp. (CIK: 0001533998)

Registration Statement No. 333-224458 on Form S-3 (the “Registration Statement”)

Ladies and Gentlemen:

DarioHealth Corp. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on May 16, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

Very truly yours,
DARIOHEALTH CORP.

Show Raw Text
CORRESP
1
filename1.htm

DarioHealth Corp.

8 HaTokhen Street

Caesarea Industrial Park

3088900, Israel

May 14, 2018

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    DarioHealth Corp. (CIK: 0001533998)

    Registration Statement No. 333-224458 on Form S-3 (the “Registration Statement”)

Ladies and Gentlemen:

DarioHealth Corp. (the
“Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement
pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become
effective on May 16, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The Registrant understands
that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration
Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act and the Securities
Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration
Statement.

    Very truly yours,

    DARIOHEALTH CORP.

    By: /s/ Zvi Ben David

    Zvi Ben David, Chief Financial Officer